FR EA

Contract analysis

Clause-by-clause risk read on any document of the firm. Pick a contract, or open any document from a matter.

Contract analysis / indications-for-use-draft-form-3881.docx
indications-for-use-draft-form-3881.docx
1037-00002 · 1 clauses
High · 1 Medium · 0 Standard · 0
FORM FDA 3881 (DRAFT) High
⚑ Penalty / liquidated damages
FORM FDA 3881 (DRAFT) INDICATIONS FOR USE STATEMENT DRAFT — Prepared by Calderwood & Harkness LLP for Solstice Biomedical Inc. Engagement Reference: 1037-00002 Draft dated for inclusion in the 510(k) submission targeted for April 30, 2026 NOTICE: Not for submission — subject to revision pending Pre-Sub feedback and final clinical data. This document constitutes attorney work product prepared in anticipation of regula